|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.44XA |
Capsular contracture of breast implant, initial encounter
|
T8544XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.72%
|
26.81%
|
8.93%
|
4.31%
|
1.66%
|
0.85%
|
0.43%
|
0.24%
|
0.21%
|
0.17%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.44XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
1,547
|
3,058
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,431
|
5,639
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,412
|
6,512
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,238
|
42,043
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,055
|
7,365
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
802
|
1,612
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
799
|
7,739
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
769
|
1,108
|
|
J1170
|
HYDROMORPHONE INJECTION |
701
|
1,094
|
|
J7120
|
RINGERS LACTATE INFUSION |
680
|
983
|
|
88300
|
SURGICAL PATH GROSS |
676
|
973
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
674
|
674
|
|
19371
|
PERI-IMPLT CAPSLC BRST COMPL |
669
|
670
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
624
|
941
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
585
|
913
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
562
|
1,437
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
488
|
686
|
|
J2001
|
LIDOCAINE INJECTION |
402
|
5,182
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
384
|
1,392
|
|
J0131
|
INJ, ACETAMINOPHEN (NOS) |
379
|
37,753
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.44XA related to the following DRG Codes:
600-601
|
